Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 114 results for "Vivitrol"

Rehab After Work Now Offers Vivitrol Injections

As a longtime provider of drug and alcohol addiction treatment in Pennsylvania and New Jersey, Rehab After Work remains focused on offering cutting-edge services. Along with traditional counseling services provided by Rehab After Work, the continued ... PRWeb, 2 weeks ago

How Alkermes Transformed an Anti-Addiction Drug From a Bust to a Hit

The promise seemed huge. In 2005 a Boston biotech, Alkermes ALKS 2.49% , developed a drug to fight addiction. Injected once a month, Vivitrol blocks brain receptors and prevents addicts from getting high. The FDA initially approved it to treat ...
 BioSpace15 minutes ago How a Biotech Turned a Bust Into a Hit  Fortune1 day ago New program offered at jail helps inmates beat drug addiction  Corrections Connection1 month ago
American Banking News

Zacks Investment Research Lowers Alkermes PLC (ALKS) to Hold

Alkermes PLC (NASDAQ:ALKS) According to Zacks, Alkermes boasts a diversified portfolio of products targeting major CNS disorders including schizophrenia, depression, addiction and multiple sclerosis. Revenues are driven not only by the company's ...
 American Banking News19 hours ago Alkermes PLC (ALKS) Downgraded by Zacks Investment Research  American Banking News20 hours ago Zacks Investment Research Upgrades Alkermes PLC (ALKS) to Buy  WKRB News1 month ago Alkermes PLC (ALKS) Upgraded to Buy at Zacks Investment Research  Mideast Time1 month ago

Suboxone suit alleges monopoly

On Friday 35 state attorneys general filed an anti-trust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause ...
 Arizona Daily Star19 hours ago

Equities Research Analysts Updated EPS Estimates for September, 27th (ABDNY, ALKS, BLT, BOO, BSY, CARD, COB, GTOMY, IBM, LHA)

Equities Research Analysts updated eps estimates for Tuesday, September 27th: ABERDEEN ASSET MGT UNSPON ADR EA REPR 2 (NASDAQ:ABDNY) was downgraded by analysts at Goldman Sachs Group Inc. from a neutral rating to a sell rating. Alkermes PLC ...
 SleekMoney20 hours ago

drug addiction treatments the role of long acting naltrexone

Drug-related convictions place a substantial burden on the criminal justice system and on society. The MD Magazine Peer Exchange Medication-Assisted Treatment in Drug Abuse Cases: A Path to Success features a panel of experts in the criminal justice ...
 HCPLive1 day ago New Treatment Needed For Drug Detox In Jails, Some Officials Say  Inquisitr3 weeks ago

There's big volatility ahead for this sector: Goldman Sachs

The market in autumn tends to see an uptick in volatility — and Goldman Sachs forecasts the health-care sector could see a particularly rocky upcoming month. The investment bank's options research team, in a note published last week, said it is ...
 CNBC2 days ago

Some insurers thwart efforts to use medication treatment for addiction

Krista Sizemore of Newport is photographed at her mother's home.(Photo: Carrie Cochran) Krista Sizemore's brain was crying out for heroin. But she knew she was pregnant. She knew her baby needed her to stay safe. She knew what could happen if she ...
 USA Today2 days ago

Why is Opioid Addiction so Difficult to Overcome?

( - "Addiction is a complex disease," says Dr. Surasky. "It is caused by a combination of biological, behavioral, and environmental factors, all of which have to be addressed to effect a cure. Understanding how opioids change ...
 HealthNewsDigest.com5 days ago The Opioid Crisis: Which Treatments Work for those Suffering with Addiction?  HealthNewsDigest.com1 week ago This Is Your Brain on Opioids  HealthNewsDigest.com1 month ago This Is Your Brain on Opioids: Tips on Understanding Addiction and Recovery  Benzinga.com1 month ago

Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug

It was an exceptionally good week for the biotech sector with the market reacting positively to pharma company Allergan's acquisition deals with biotech stocks. Expectations are that more such deals will be announced with biotech companies like ...
 Zacks.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less